Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: EBD Group Conference

MRI Interventions Inc. (MRIC) Starts Presentation at the Biotech Showcase 2013 Conference

MRI Interventions is a medical device company that develops and commercializes platforms for procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company has two product platforms: ClearPoint, in commercial use in the U.S. … Continue reading

Posted in EBD Group Conference | Leave a comment

CytoDyn Inc. (CYDY) Starts Presentation at the Biotech Showcase 2013 Conference

CytoDyn is a biotech company focused on developing new therapies for combating infection with immune deficiency viruses and other antibody applications. Its proprietary drug candidate PRO 140 is a humanized monoclonal antibody which has demonstrated the ability to block the … Continue reading

Posted in EBD Group Conference | Leave a comment

Astex Pharmaceuticals Inc. (ASTX) Starts Presentation at the Biotech Showcase 2013 Conference

Astex Pharmaceuticals is an innovative drug discovery, development and commercialization company focusing on therapeutics to fight against cancer and other life-threatening diseases. The company’s primary areas of focus are oncology and hematology. ASTX has established a broad pipeline of small … Continue reading

Posted in EBD Group Conference | Leave a comment

CollabRX Inc. (CLRX) Starts Presentation at the Biotech Showcase 2013 Conference

CollabRX is a data analytics company that uses cloud-based expert systems to inform healthcare decision-making. CLRX’s CollabRx Therapy Finders is a series of Web-based applications that provide information to physicians and patients for determining which medical tests, therapies and clinical … Continue reading

Posted in EBD Group Conference | Leave a comment

Retrophin (RTRX) Starts Presentation at the Biotech Showcase 2013 Conference

Retrophin is a biotech company focused on discovering and developing treatments for rare and life-threatening diseases. RTRX is currently developing treatments for Focal Segmental Glomerulosclerosis (FSGS), Pantothenate Kinase-Associated Neurodegeneration (PKAN), Duchenne Muscular Dystrophy and other catastrophic diseases. The company’s lead … Continue reading

Posted in EBD Group Conference | Leave a comment

SpectraScience Inc. (SCIE) Starts Presentation at the Biotech Showcase 2013 Conference

SpectraScience is a medical device company that designs, develops, manufactures and markets light-based analysis systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The company’s WavSTAT Optical Biopsy System uses light … Continue reading

Posted in EBD Group Conference | Leave a comment

Bioniche Life Sciences (BNHLF) Starts Presentation at the Biotech Showcase 2013 Conference

Bioniche Life Sciences is a research-based biopharm company that discovers, develops, manufactures and markets proprietary products for human and animal health markets. The company operates three global business divisions: human health, animal health and food safety. BNC’s Urocidin™ is a … Continue reading

Posted in EBD Group Conference | Leave a comment

AmpliPhi Biosciences Corp. (APHB) Starts Presentation at the Biotech Showcase 2013 Conference

AmpliPhi Biosciences is a biotech company engaged in the development of anti-bacterial solutions to enhance human health through the application of its proprietary bacteriophage platform. Its lead product development programs target gram negative bacterial infections that are resistant to antibiotic … Continue reading

Posted in EBD Group Conference | Leave a comment

Allied Healthcare Group (BOMDF) Starts Presentation at the Biotech Showcase 2013 Conference

Allied Healthcare Group is a diversified healthcare company focused on investing in next generation technologies, acquiring strategic assets to grow its product and service offerings. BOMDF operates in three businesses: Cordion, focused on vaccine technology for the prevention of infectious … Continue reading

Posted in EBD Group Conference | Leave a comment

Aradigm Corp. (ARDM) Starts Presentation at the Biotech Showcase 2013 Conference

Aradigm is engaged in developing inhalation drug products designed to improve the quality of life of patients with severe pulmonary disease. The company’s lead development candidates are formulations of the potent antibiotic ciprofloxacin (Pulmaquin (ARD-3150) and Lipoquin (ARD-3100), which is … Continue reading

Posted in EBD Group Conference | Leave a comment